|
1
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fleischmann C, Scherag A, Adhikari NK,
Hartog CS, Tsaganos T, Schlattmann P, Angus DC and Reinhart K;
International Forum of Acute Care Trialists, : Assessment of global
incidence and mortality of hospital-treated sepsis. Current
estimates and limitations. Am J Respir Crit Care Med. 193:259–272.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen X, Wang T, Song L and Liu X:
Activation of multiple toll-like receptors serves different roles
in sepsis-induced acute lung injury. Exp Ther Med. 18:443–450.
2019.PubMed/NCBI
|
|
4
|
Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R,
Hu B, Cao H, Xu L, Liu M, et al: Adaptive EGF expression sensitizes
pancreatic cancer cells to ionizing radiation through activation of
the cyclin D1/P53/PARP pathway. Int J Oncol. 54:1466–1480.
2019.
|
|
5
|
Hong G, Zheng D, Zhang L, Ni R, Wang G,
Fan GC, Lu Z and Peng T: Administration of nicotinamide riboside
prevents oxidative stress and organ injury in sepsis. Free Radic
Biol Med. 123:125–137. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanling Q, Xiaoning C, Fei B, Liyun F,
Huizhong H and Daqing S: Inhibition of NLRP9b attenuates acute lung
injury through suppressing inflammation, apoptosis and oxidative
stress in murine and cell models. Biochem Biophys Res Commun.
503:436–443. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Darakhshan S and Pour AB: Tranilast: A
review of its therapeutic applications. Pharmacol Res. 91:15–28.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abe S, Makimura S, Kawakami Y, Yamamoto H,
Nojima T and Inoue K: Cytomorphologic features of antiallergic
drug-induced eosinophilic cystitis with bronchial asthma. Hokkaido
Igaku Zasshi. 62:907–912. 1987.
|
|
9
|
Nader MA, Gameil N, Abdelaziz RR, Zalata
KR, Osman A, Zedan MM, Abo-Elkheir N, Elsiddig AA and Zedan M:
Effect of tranilast in comparison with beclomethasone in chronic
murine model of asthma. Exp Lung Res. 42:296–306. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Suzuki K, Nagata M, Kawauchi Y,
Yano M, Ohkoshi S, Matsuda Y, Kawachi H, Watanabe K, Asakura H and
Aoyagi Y: Rectal administration of tranilast ameliorated acute
colitis in mice through increased expression of heme oxygenase-1.
Pathol Int. 60:93–101. 2010. View Article : Google Scholar
|
|
11
|
Chen S, Pan Y, Zheng S, Liu Y, Xu J, Peng
Y, Zhang Z, Wang Y, Xiong Y, Xu L, et al: Novel role for tranilast
in regulating NLRP3 ubiquitination, vascular inflammation, and
atherosclerosis. J Am Heart Assoc. 9:e0155132020. View Article : Google Scholar
|
|
12
|
Pae HO, Jeong SO, Koo BS, Ha HY, Lee KM
and Chung HT: Tranilast, an orally active anti-allergic drug,
up-regulates the anti-inflammatory heme oxygenase-1 expression but
down-regulates the pro-inflammatory cyclooxygenase-2 and inducible
nitric oxide synthase expression in RAW264.7 macrophages. Biochem
Biophys Res Commun. 371:361–365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzawa H, Kikuchi S, Ichikawa K and Koda
A: Inhibitory action of tranilast, an anti-allergic drug, on the
release of cytokines and PGE2 from human monocytes-macrophages. Jpn
J Pharmacol. 60:85–90. 1992. View Article : Google Scholar
|
|
14
|
Said E, Elkashef WF and Abdelaziz RR:
Tranilast ameliorates cyclophosphamide-induced lung injury and
nephrotoxicity. Can J Physiol Pharmacol. 94:347–358. 2016.
View Article : Google Scholar
|
|
15
|
Kato M, Takahashi F, Sato T, Mitsuishi Y,
Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I,
et al: Tranilast inhibits pulmonary fibrosis by suppressing
TGFβ/SMAD2 pathway. Drug Des Devel Ther. 14:4593–4603. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen S, Wang Y, Pan Y, Liu Y, Zheng S,
Ding K, Mu K, Yuan Y, Li Z, Song H, et al: Novel role for tranilast
in regulating NLRP3 ubiquitination, vascular inflammation, and
atherosclerosis. J Am Heart Assoc. 9:e0155132020. View Article : Google Scholar
|
|
17
|
Darakhshan S, Bidmeshkipour A, Mansouri K,
Saeid HM and Ghanbari A: The effects of tamoxifen in combination
with tranilast on CXCL12-CXCR4 axis and invasion in breast cancer
cell lines. Iran J Pharm Res. 13:683–693. 2014.PubMed/NCBI
|
|
18
|
Hirano Y, Ode Y, Ochani M, Wang P and Aziz
M: Targeting junctional adhesion molecule-C ameliorates
sepsis-induced acute lung injury by decreasing CXCR4(+) aged
neutrophils. J Leukoc Biol. 104:1159–1171. 2018. View Article : Google Scholar
|
|
19
|
Liang T, Wang B, Li J and Liu Y: LINC00922
Accelerates the proliferation, migration and invasion of lung
cancer via the miRNA-204/CXCR4 axis. Med Sci Monit. 25:5075–5086.
2019. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dickson RP, Singer BH, Newstead MW,
Falkowski NR, Erb-Downward JR, Standiford TJ and Huffnagle GB:
Enrichment of the lung microbiome with gut bacteria in sepsis and
the acute respiratory distress syndrome. Nat Microbiol.
1:161132016. View Article : Google Scholar
|
|
22
|
Rubenfeld GD, Caldwell E, Peabody E,
Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and
outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villar J, Sulemanji D and Kacmarek RM: The
acute respiratory distress syndrome: Incidence and mortality, has
it changed? Curr Opin Crit Care. 20:3–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang L, Dong Y, Wu J, Wang P, Zhou H, Li
T and Liu L: Sinomenine-induced histamine release-like
anaphylactoid reactions are blocked by tranilast via inhibiting
NF-κB signaling. Pharmacol Res. 125:150–160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimizu T, Kanai K, Kyo Y, Asano K,
Hisamitsu T and Suzaki H: Effect of tranilast on matrix
metalloproteinase production from neutrophils in-vitro. J Pharm
Pharmacol. 58:91–99. 2006. View Article : Google Scholar
|
|
26
|
Hiraide S, Yanagawa Y and Iizuka K:
Tranilast inhibits interleukin-33 production by macrophages. Eur J
Pharmacol. 818:235–240. 2018. View Article : Google Scholar
|
|
27
|
Hanada M, Tsutsumi K, Arima H, Shinjo R,
Sugiura Y, Imagama S, Ishiguro N and Matsuyama Y: Evaluation of the
effect of tranilast on rats with spinal cord injury. J Neurol Sci.
346:209–215. 2014. View Article : Google Scholar
|
|
28
|
Huang Y, Jiang H, Chen Y, Wang X, Yang Y,
Tao J, Deng X, Liang G, Zhang H, Jiang W and Zhou R: Tranilast
directly targets NLRP3 to treat inflammasome-driven diseases. EMBO
Mol Med. 10:e86892018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang WY, Ren J, Zhang XH, Lu ZL, Feng HJ,
Yao XL, Li DH, Xiong R, Fan T and Geng Q: CircC3P1 attenuated
pro-inflammatory cytokine production and cell apoptosis in acute
lung injury induced by sepsis through modulating miR-21. J Cell Mol
Med. 24:11221–11229. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu J, Zhao Y and Aisa HA:
Anti-inflammatory effect of pomegranate flower in
lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Pharm
Biol. 55:2095–2101. 2017. View Article : Google Scholar
|
|
31
|
Li P and Schwarz EM: The TNF-alpha
transgenic mouse model of inflammatory arthritis. Springer Semin
Immunopathol. 25:19–33. 2003. View Article : Google Scholar
|
|
32
|
Liu R, Xu KP and Tan GS: Cyclooxygenase-2
inhibitors in lung cancer treatment: Bench to bed. Eur J Pharmacol.
769:127–133. 2015. View Article : Google Scholar
|
|
33
|
Choi S, Lim JW and Kim H: Effect of thiol
antioxidants on lipopolysaccharide-induced cyclooxygenase-2
expression in pulmonary epithelial cells. J Physiol Pharmacol.
69:127–133. 2018.
|
|
34
|
Zheng H, Liang W, He W, Huang C, Chen Q,
Yi H, Long L, Deng Y and Zeng M: Ghrelin attenuates sepsis-induced
acute lung injury by inhibiting the NF-κB, iNOS, and Akt signaling
in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol.
317:L381–L391. 2019. View Article : Google Scholar
|
|
35
|
Strien L, Joensuu K, Heikkila P and
Leidenius MH: Different expression patterns of CXCR4, CCR7, maspin
and FOXP3 in luminal breast cancers and their sentinel node
metastases. Anticancer Res. 37:175–182. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pozzobon T, Goldoni G, Viola A and Molon
B: CXCR4 signaling in health and disease. Immunol Lett. 177:6–15.
2016. View Article : Google Scholar
|
|
37
|
McClendon J, Jansing NL, Redente EF,
Gandjeva A, Ito Y, Colgan SP, Ahmad A, Riches DW, Chapman HA, Mason
RJ, et al: Hypoxia-inducible factor 1α signaling promotes repair of
the alveolar epithelium after acute lung injury. Am J Pathol.
187:1772–1786. 2017. View Article : Google Scholar
|
|
38
|
Kanehisa M and Goto S: KEGG: kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
